Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men

Journal of the American College of Cardiology

Volumn 37, Issue 1, 2001, Pages 130-136

  Tadamura, Eiji ^a   Iida, Hidehiro ^b   Matsumoto, Keiichi ^a   Mamede, Marcelo ^a   Kubo, Shigeto ^a   Toyoda, Hiroshi ^a   Shiozaki, Toshiki ^a   Mukai, Takahiro ^a   Magata, Yasuhiro ^a   Konishi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DIPYRIDAMOLE; DOBUTAMINE;

ADULT; ARTICLE; HEADACHE; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART PALPITATION; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; ATROPINE; CORONARY CIRCULATION; DIPYRIDAMOLE; DOBUTAMINE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; REFERENCE VALUES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035162464     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01043-3     Document Type: Article

References (40)

1. Myocardial imaging with thallium-201 at rest and during exercise. Comparison with coronary arteriography and resting and stress electrocardiography
2. Exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease
3. Effect of aging on myocardial perfusion reserve
4. Early impairment of coronary flow reserve in young men with borderline hypertension
5. Coronary flow reserve in young men with familial combined hyperlipidemia
6. Safety profile of adenosine stress perfusion imaging: Results from the Adenoscan Multicenter Trial Registry
7. 15O-labeled water and PET
8. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate
9. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing
10. Dobutamine stress: Effects on regional myocardial blood flow and wall motion
11. Tolerance, hemodynamic changes, and safety of dobutamine stress perfusion imaging
12. Dobutamine positron emission tomography: Absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease
13. Measurement of myocardial blood flow with positron emission tomography before and after transmyocardial laser revascularization
14. Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. Multicenter trial for evaluation of safety and diagnostic accuracy
15. N-13 ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography
16. Pharmacologic stress testing: Mechanism of action, hemodynamic responses, and results in detection of coronary artery disease
17. State of the art for coronary artery disease detection: Thallium-201
18. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography
19. Atropine augmentation in dobutamine stress echocardiography: Role and incremental value in a clinical practice setting
20. Nonexercise stress transthoracic echocardiography: Transesophageal atrial pacing versus dobutamine stress
21. Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction
22. Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease
23. Prediction of cardiac events after uncomplicated acute myocardial infarction by clinical variables and dobutamine stress test
24. Dobutamine-atropine stress echocardiography for the detection of coronary artery disease in patients with left ventricular hypertrophy importance of chamber size and systolic wall stress
25. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both?
26. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy
27. Dobutamine stress thallium-201 single-photon emission tomography versus echocardiography for evaluation of the extent and location of coronary artery disease late after myocardial infarction
28. The significance of stress-induced ST segment depression in patients with inferior Q wave myocardial infarction
29. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease
30. Performance characteristics of a whole-body PET scanner
31. Reciprocal ST-segment depression associated with exercise-induced ST-segment elevation indicates residual viability after myocardial infarction
32. Iterative reconstruction based on median root prior in quantification of myocardial blood flow and oxygen metabolism
33. 15O and dynamic positron-emission tomography: Strategy for quantification in relation to the partial-volume effect
34. Myocardial tissue fraction-correction for partial volume effects and measure of tissue viability
35. Quantitative assessment of regional myocardial blood flow using oxygen-15-labelled water and positron emission tomography: A multicentre evaluation in Japan
36. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography
37. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography
38. Dipyridamole
39. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine
40. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging